Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD Suppositories for Interstitial Cystitis
NCT04349930Phase 1Withdrawn
- Sponsor
- The University of New Mexico
- Start
- Jan 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in interstitial cystitis (IC) comparing Cannabidiol with Placebo (2 arms). Primary endpoint: Urinary Pain Severity Scores at 6 weeks. Planned start Jan 2021; status: withdrawn.
02
Drugs
cannabidiol
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT04349930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04349930.